Impact of emphysema on the therapeutic efficacy and risk of immune-rel

Introduction

Non-small cell lung cancer (NSCLC) is one of the most prevalent and deadly malignancies worldwide.¹ In recent years, immune checkpoint inhibitors (ICIs), such as programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1)…